February 10, 2020 / 11:11 PM / 11 days ago

BRIEF-Moderna Announces First Patient Enrolled In Phase 1/2 Study Of Mrna-3704 For Methylmalonic Acidemia

Feb 10 (Reuters) - Moderna Inc:

* MODERNA ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 1/2 STUDY OF MRNA-3704 FOR METHYLMALONIC ACIDEMIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below